Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for patients with severe and life-threatening diseases.
Range dropdown markets
Sectors
Nasdaq
After hours
EDT Delayed quote
$ 2.8600
0.00 0.00%
After Hours Volume: 30.26K
Close Chg Chg
$2.8600 -0.0100 -0.35%
Volume: 1.12M 65-Day Average: 1.35M
83% vs Average 2.7700 Days Range 2.9700 to 2.6600 52-Week Range 10.0100
Key Data
% of Float Shorted 15.45%
Average Volume 1.35M
Performance
5 Days
-5.30%
1 Month
-29.56%
3 Months
-4.35%
YTD
-12.80%
1 Year
-69.57%
Other News Press Releases
89bio (ETNB), Up 25% on Upbeat data from Mid-Stage NASH study
Mar. ET on Zacks.com
Sanofi's (SNY), Dupixent Meets Pivotal COPD Study Goal
Mar. ET on Zacks.com
Karuna's (KRTX), KarXT Reaches Primary Goal in Schizophrenia Research
Mar. ET on Zacks.com
Esperion (ESPR), Drops 54% During Milestone Payment Row
Mar. ET on Zacks.com
Merck's (MRK), Co-formulation Therapy Failed Lung Cancer Study
Mar. ET on Zacks.com
Atara Biotherapeutics's Return on Capital Employed
February 10, 2023, 9:50 a.m. ET on Benzinga.com
Analysts have Conflicting Views on these Healthcare Companies: Galapagos, Atara Biotherapeutics and Teva Pharmaceutical (TEVA).
February 9, 2023, 7:40 a.m. ET at TipRanks.com
Mizuho Securities Maintains their Buy Rating for Atara Biotherapeutics.
Twelve Health Care Stocks Move In Wednesday's After Market Session
February 8, 2023, 4:31 p.m. ET on Benzinga.com
Why Bed Bath & Beyond fell nearly 30%; Here are 20 stocks that are moving premarket
Mizuho Securities Maintains their Buy Rating for Atara Biotherapeutics.
Benzinga's Top Rated Ratings Upgrades and Downgrades for January 5, 2023
Li Auto, XPeng and Nio Move Higher in Today's Premarket Session
Three Under-the-Radar Biotech Stocks You Should Buy in 2022
Dec. 24, 2022, 10:07 a.m. ET on Motley Fool
Atara (NASDAQ,ATRA) to Receive $31 million to Propagate Epstein-Barr Therapy
Dec. 21, 2022, 2:45 a.m. ET on TipRanks.com
Twelve Health Care Stocks Move In Tuesday's Premarket Session
Dec. 20, 2022, 8:07 a.m. ET on Benzinga.com
Today's Top Pre-Market Stock Movers: Ten Top Gainers and 10 Top Losers on Tuesday
Atara Biotherapeutics Inc.
Atara Biotherapeutics, Inc., an allogeneic T cell immunotherapy company, develops transformative therapies for patients suffering from serious diseases such as solid tumors, hematologic and autoimmune cancers. It also provides off-the-shelf treatment to patients with high unmet needs. Tab-cel is part of the company's product portfolio. Isaac E. Ciechanover founded the company on August 22, 2012. It is located in Thousand Oaks (CA).